Intelligent Extracorporeal Blood Treatment Systems

The present inventive concept envisions a next-generation extracorporeal blood treatment system that integrates advanced technologies such as artificial intelligence, wearable devices, modular design, nanofiltration, and bio-hybrid components to revolutionize blood treatment and patient care.

The original patent described an extracorporeal blood treatment apparatus with a blood-warming device. However, this design has limitations in terms of real-time monitoring, personalized treatment, and waste generation. The new inventive concept addresses these limitations by introducing cutting-edge technologies that enable real-time optimization, personalized treatment, and reduced waste generation.

The new inventive concept comprises a system for extracorporeal blood treatment featuring an artificial intelligence module for real-time monitoring and optimization of blood warming and treatment parameters. This system can be integrated into wearable devices that incorporate miniaturized blood treatment units, blood warmers, and machine learning algorithms for adapting treatment protocols to individual patient needs. The modular, 3D-printed design enables customized treatment and reduced waste generation. Additionally, the system can incorporate a nanofiltration unit for selective removal of specific blood components and a feedback loop for real-time monitoring and adjustment of treatment efficacy. Furthermore, the wearable, implantable blood treatment device leverages bio-hybrid technology to integrate living cells with synthetic components, enabling continuous, real-time monitoring and treatment of blood disorders.

The new inventive concept's integration of artificial intelligence, wearable devices, modular design, nanofiltration, and bio-hybrid components represents a significant departure from the original patent's design. The real-time monitoring and optimization capabilities, personalized treatment, and reduced waste generation enabled by these advanced technologies constitute a novel and non-obvious inventive step.

Alternative embodiments of the inventive concept could include the use of edge computing for real-time data processing, the integration of additional sensors for monitoring patient vital signs, or the development of implantable devices with advanced biocompatibility features. Variations of the modular design could include interchangeable components for different blood treatment protocols or the use of recycled materials for reduced environmental impact.

The intelligent extracorporeal blood treatment system has significant commercial potential in the medical device industry, particularly in the areas of personalized medicine, wearable technology, and bio-hybrid devices. The target market includes hospitals, clinics, and medical research institutions, with potential applications in blood disorders, cancer treatment, and organ transplantation.